Abstract
The aim of this study was to evaluate hydroxyproline levels in nasal specimens from patients with nasal polyps, and to examine hydroxyproline levels after nasal steroid spray and oral steroid treatments. This study was performed on 41 patients. The subjects were divided into four groups: no medication group (group A, n 11), oral methylprednisolone group (group B, n 8), topical steroid spray group (group C, n 8) and control group (group D, n 14). Nasal polyp samples were collected endoscopically. Healthy subjects were studied as a control group, and their nasal samples were taken during turbine reduction surgery. All samples were analyzed using the immunocytochemistry method. Hydroxyproline levels were investigated and compared with the control group. Mean hydroxyproline levels in groups A–D were 98.48, 24.20, 8.97 and 4.52, respectively. The hydroxyproline levels were significantly higher in group A compared with that of group D. The treatment that revealed significant decreases in hydroxyproline levels was group C. Although there was also a noticeable reduction in group B, there were no statistically significant differences between group B and group A. Our study revealed a significant correlation between nasal polyp and hydroxyproline levels. The hydroxyproline levels were significantly higher in nasal polyps. Both oral and topical steroid treatments decrease hydroxyproline levels in nasal polyps. Thus, in theory, steroid treatment can directly decrease hydroxyproline levels by inhibiting proline hydroxylase and indirectly by lowering the inflammatory process.
Similar content being viewed by others
References
Lee CH, Rhee CS, Min YG (1998) Cytokine gene expression in nasal polyps. Ann Otol Rhinol Laryngol 107(8):665–670
Elovic A, Wong DT, Weller PF, Matossian K, Galli SJ (1994) Expression of transforming growth factors-α and β1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 93(5):864–869
Benson M (2005) Pathophysiological effects of glucocorticoids on nasal polyps: an update. Curr Opin Allergy Clin Immunol 5(1):31–35
Sobol SE, Fukakusa M, Christodoulopoulos P, Manoukian JJ, Schloss MD, Frenkiel S, Hamid Q (2003) Inflammation and remodeling of the sinus mucosa in children and adults with chronic sinusitis. Laryngoscope 113(3):410–414
Nelson DL, Cox MM (2005) Lehninger’s principles of biochemistry, 4th edn. W.H. Freeman, New York
DiMatteo M, Reasor MJ (1997) Modulation of silica-induced pulmonary toxicity by Dexamethasone-containing liposomes. Toxicol Appl Pharmacol 142(2):411–421
Reddy GK, Enwemeka CS (1996) A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29(3):225–229
Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Westergren-Thorsson G, Chakir J, Lafrenière-Allard MJ, Boulet LP, Tremblay GM (2002) Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int J Biochem Cell Biol 34(10):1256–1267
Watelet JB, Bachert C, Claeys C, Van Cauwenberge P (2004) Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 59(1):54–60
Molet SM, Hamid QA, Hamilos DL (2003) IL-11 and IL-17 expression in nasal polyps: Relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope 113(10):1803–1812
Mata JM, Kershenobich D, Villarreal E, Rojkind M (1975) Serum free proline and free hydroxyproline in patients with chronic liver disease. Gastroenterology 68((5 Pt 1)):1265–1269
Yamada S, Hirayama C (1983) Clinical significance of serum hydroxyproline containing peptides with special reference to hyproprotein. Eur J Clin Invest 13(2):129–133
Fernandes AM, Valera FC, Anselmo-Lima WT (2008) Mechanism of action of glucocorticoids in nasal polyposis. Braz J Otorhinolaryngol 74(2):279–283
Uchida J, Kanai K, Asano K, Watanabe S, Hisamitsu T, Suzaki H (2004) Influence of fluticasone propionate on the production of vascular endothelial growth factor and basic fibroblast growth factor from nasal fibroblasts in vitro. In Vivo 18(6):767–770
Yariktas M, Doner F, Sutcu R, Demirci M, Dogru H, Yasan H (2005) The effect of topical corticosteroid on basic fibroblast growth factor in nasal polyps tissue. Am J Rhinol 19(3):248–250
Hirano S, Asano K, Namba M, Kanai K, Hisamitsu T, Suzaki H (2003) Induction of apoptosis in nasal polyp fibroblasts by glucocorticoids in vitro. Acta Otolaryngol 123(9):1075–1079
Lu Y, Fukuda K, Liu Y, Kumagai N, Nishida T (2004) Dexamethasone inhibition of IL-1-induced collagen degradation by corneal fibroblasts in three-dimensional culture. Invest Ophthalmol Vis Sci 45(9):2998–3004
Durmus M, Karaaslan E, Ozturk E, Gulec M, Iraz M, Edali N, Ersoy MO (2003) The effects of single-dose dexamethasone on wound healing in rats. Anesth Analg 97(5):1377–1380
Acknowledgments
The authors would like to acknowledge Ozlem Koksal for statistical analysis.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cincik, H., Kapucu, B., Ipcioglu, O.M. et al. Hydroxyproline levels in nasal polyps. Eur Arch Otorhinolaryngol 268, 1147–1150 (2011). https://doi.org/10.1007/s00405-011-1546-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-011-1546-6